PX'Therapeutics is authorised by the French competent authority for manufacturing operations of investigational medicinal products (according to Good Manufacturing Practice Part I).
GMP certificate number: HPF/FR/24/2013 in the EudraGMP database.
In this context, PX'Therapeutics offers process scale up, preclinical and GMP manufacturing services for both microbial (E.coli, yeasts) and mammalian-based recombinant products.
We can handle in-house-developed processes or processes developed by other CRO/CMO or academic labs.
Our GMP-compliant process-transfer expertise is built by bringing together the optimal performances of our experienced team members to ensure a successful process transfer to PX'Therapeutics. Therefore, close communication between the parties is set up.